Orthofix Reports Fourth Quarter and Fiscal Year 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Orthofix International (OFIX) Tops Q4 EPS by 25c, Revenues Beat; Offers FY21 EPS/Revenue Outlook
February 26, 2021 7:04 AM ESTOrthofix International (NASDAQ: OFIX) reported Q4 EPS of $0.44, $0.25 better than the analyst estimate of $0.19. Revenue for the quarter came in at $117.6 million versus the consensus estimate of $113.2 million.
Fourth quarter net sales of $117.6 million, within 3% of our 2019 resultsUS Spine implant sales grew 11% compared to fourth quarter 2019, driven by record M6-C artificial cervical disc performanceStrong cash flow performance in the quarter, free cash flow of $17.9 millionFITBONE® intramedullary lengthening and deformity system receives FDA clearance for pediatric indicationWe were very pleased with our performance during... More
